Vstm stocktwits.

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK.What is VSTM's Insider Trend? What is the meaning of the following actions: Amount: When there is an accurate amount available in the form 4 filing, it will be shown. If an accurate amount is not available, we will show the Estimated Value which is a unique TipRanks calculation that shows the financial impact of insider transactions on a company.1,581,848. 4.791819. Back to VSTM Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and ...Institutional investors purchased a net $4.5 million shares of VSTM during the quarter ended June 2019, and now own 43.98% of the total float, a percentage that is typical for companies in the ...

See Verastem, Inc. (VSTM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.View the VSTM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Verastem Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VSTM ...

Curated by Yahoo Finance. Follow this list to discover and track penny stocks with the highest daily volume. The list includes stocks priced at $5 or less with a day change greater than 3%. This ...In December 2021, after years of development suspension, we released FBReader 2.0 for Linux. Although the app includes most iOS and Android reader features, this is not a port of the mobile version. It is designed especially for desktop/laptop computers. FBReader 2.0 is free of charge but not open-source. Currently, it is available in two formats:

The stock has traded between $1.44 and $1.55 so far today. Volume today is below average. So far 3,882,570 shares have traded compared to average volume of 5,444,876 shares. Analysts who follow Verastem Inc (VSTM) on average expect it to increase 161.44% over the next twelve months. Those same analysts give the stock an average rating of Strong ...VSTM. Stock : USD 0.34 0.0036 1.06% : Verastem Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Verastem historical stock prices and determine the direction of Verastem's future trends based on various well-known forecasting models. However, solely looking at the historical price ...Send a secure message, set an appointment, e-sign documents and stay in touch with your advisor. See how it works.Based on analysts offering 12 month price targets for VSTM in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. VSTM. stock. Shares. Market price $9.56. Fee $0.00. Total $0.00. Open Account. Analyst Top Buys & Sells. Analyst Top Buys & Sells. An aggregated list of the top rated and lowest rated securities across a selection of analysts (provided by Benzinga).

VSTM : 7.75 (+4.73%) Markets Today: Stocks Firm on Hopes for Additional Chinese Stimulus Barchart - Fri Jun 16, 7:56AM CDT. Morning Markets June E-Mini S&P 500 futures (ESM23 ) this morning are up +0.19%, and June Nasdaq 100 E-Mini futures (NQM23 ) are up +0.37%. U.S. stock index futures this morning are moderately higher....

Fundamentals. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...

BOSTON, August 08, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the ...Q4 2023 EPS Estimate Trends. Current. -$0.67. 1 Month Ago. -$0.66. 3 Months Ago. -$0.82. Verastem Inc. analyst estimates, including VSTM earnings per share estimates and analyst recommendations.About the Verastem, Inc. stock forecast. As of 2023 September 16, Saturday current price of VSTM stock is 9.880$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Verastem stock price as been showing a rising tendency so we believe that similar market segments were very popular in the …Over the last year, we can see that the biggest insider purchase was by Independent Director Timothy Barberich for US$109k worth of shares, at about US$2.17 per share. That means that an insider ...View the top 10 symbols with the most trending streams on Stocktwits right now. Check back every five minutes for updates. Trending. Most Active. Watchers. Position. Symbol. Score. Last Price %Change. Watch. Join the conversation. This is where all the magic happens.Track Tesla Inc (TSLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Oct 5, 2023 · VSTM US92337C2035 Delayed Nasdaq. Other stock markets. 04:00:00 2023-10-05 pm EDT 5-day change 1st Jan Change 7.750 USD ... Company Summary. Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal ...2 Disclaimers This presentation includes forward-looking statements about, among other things, Verastem Oncology's programs and product candidates, including anticipated regulatory submissions, approvals, performance and potential benefits of Veraste 9 days ago . VERASTEM, INC.All groups and messages ... ...Sep 29, 2023 · Find the latest Verastem, Inc. (VSTM) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. View the VSTM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Verastem Inc real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VSTM ...

Verastem has a market cap or net worth of $191.91 million as of October 10, 2023. Its market cap has increased by 20.24% in one year. Market Cap. 191.91M. Enterprise Value. 61.43M. 1-Year Change. 20.24%. Ranking.

msn.com - July 3 at 6:04 PM. Truist Securities Reiterates Verastem (VSTM) Buy Recommendation. nasdaq.com - June 28 at 10:15 AM. Truist Financial Keeps Their Buy Rating on Verastem (VSTM) markets.businessinsider.com - June 27 at 12:43 PM. Verastem Oncology stock down on raising $85M equity capital.music producer studio "Bankroll" - YG Type Beat 2018 - Bay Area/West Coast Type InstrumentalVerastem gets $3.8M award for VS-6766/defactinib combo trial to treat pancreatic cancer. SA NewsWed, May 18, 2022.Put/Call Open Interest Ratio: The total put open interest divided by the total call open interest for the expiration date. Implied Volatility: The average implied volatility of the calls and puts immediately above and below the underlying price. The bottom of the page recaps grand totals for the fields shown.Earnings Summary. For their last quarter, Verastem (VSTM) reported earnings of -$1.37 per share, missing the Zacks Consensus Estimate of -$1.13 per share. This reflects a negative earnings ...Find the latest Microvast Holdings, Inc. (MVST) stock quote, history, news and other vital information to help you with your stock trading and investing.Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...

Verastem. Revenue. In the year 2022, Verastem had annual revenue of $2.60M with 26.45% growth.

By Karl Utermohlen, InvestorPlace Writer Dec 15, 2017. DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote …Olympiad Research LP Takes $276,000 Position in Cleveland-Cliffs Inc. (NYSE:CLF) Cleveland-Cliffs Larger Than S&P 500 Component Universal Health Services. Track Cleveland-Cliffs Inc (CLF) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the …Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 - 2011; RevenueView. Track Verastem Inc (VSTM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights …Analysis of Verastem (VSTM). Explore news, insider trading, bankruptcy risk and more.Track Occidental Petroleum Corp. (OXY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem (VSTM) In a report issued on February 13, Gregory Renza from RBC Capital maintained a Buy rating on Verastem, with a price target of $3.00. The company's shares closed last Wednesday at $0.59, close to its 52-week low of $0.29. According to TipRanks. Mar 15, 2023 . Financial Summary. Share Statistics: VSTM: …Verastem (VSTM) Stock Price Performance. Verastem (VSTM) Stock Key Data. Summary Additional Data Analysts Historical QuotesThe value each VSTM share was expected to gain vs. the value that each VSTM share actually gained.. Verastem (VSTM) reported Q2 2023 earnings per share (EPS) of-$1.37, missing estimates of -$1.04 by 31.24%.In the same quarter last year, Verastem's earnings per share (EPS) was-$1.41.Verastem is expected to release next earnings on 11/02/2023, with an earnings per share (EPS) estimate of-$0.84.Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 - 2011; RevenueVSTM : Verastem stock forecast by Wall Street Analysts. The average Verastem stock forecast from last 6 month is $34.09, and this show a -5.88% decrease in average from the prior price target of the each prediction. Also, this average forecast of $34.09 represents a 975.39% increase from the past average forecast of $3.17, 6 months ago from 6 wall street analysts.

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...All groups and messages ... ...VSTM Performance. The chart shows the growth of $10,000 invested in Verastem, Inc. in Jan 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $397 for a total return of roughly -96.03%. All …VSTM / Verastem Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5 Verastem Inc. SHARE PRICE. EXTENDED. Day's Range - 52 Week Range - Pharmaceutical Preparatio... Are you a Financial Writer? Become a Fintel Contributor Today. Shares Outstanding: 25,250,711 shares: Insider Shares: 3,615,695 shares: Insider Ownership:Instagram:https://instagram. kalani and asuelu net worthcraigslist riverdale garise rock creek menuhow to get white crafter scrips ffxiv Verastem Inc (VSTM) Stock Price & News - Google Finance Markets Europe Dow Jones 33,362.04 -0.14% -45.54 S&P 500 4,300.14 -0.19% -8.36 Nasdaq 13,360.11 -0.53% -71.23 Russell 1,735.99 -0.55%...13,219.83 -16.18(-.12%) Russell 2000 1,731.51 +2.50(+0.14%) Crude Oil 82.56 -1.66(-1.97%) Gold 1,834.30 -0.50(-0.03%) Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD... grave warden pyromancy tomeweather cedar park tx radar Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.Oct 6, 2023 · Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants. BOSTON-- (BUSINESS WIRE)--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten pu... summerfest prodigy 2023 Get The Stocktwits Daily Rip. This room is for long term investors in the small and mid-cap biotech space with a focus on VSTM. According to 7 stock analysts, the average 12-month stock price forecast for Verastem stock is $35.14, which predicts an increase of 344.81%. The lowest target is $21 and the highest is $60. On average, analysts rate Verastem stock as a strong buy.Verastem (VSTM) stock is jumping after the company reported a narrower-than-expected loss for the 2015 fourth quarter. VSTM. OPINION. Mar 2, 2016 6:57 AM EST.